RECRUITING

Genomic Sequencing in Anatomically Normal Fetuses

Talk to us

Conditions

Pregnant Individuals Requesting Standard Microarray

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indications other than a structural fetal anomaly.

Official Title

Genomic Sequencing in Anatomically Normal Fetuses

Quick Facts

Study Start:2024-01-01
Study Completion:2030-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06211348

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 64 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant with a structurally normal fetus (singleton or multiple gestation)
  2. * Planning to undergo prenatal diagnosis by either chorionic villus sampling or amniocentesis with chromosome microarray analysis for routine indications
  3. * Planning, or have already completed expanded carrier screening
  1. * Decline prenatal diagnostic testing
  2. * Are pregnant and their fetus has a known anomaly
  3. * Declined chromosomal microarray analysis of expanded carrier screening

Contacts and Locations

Study Contact

Nuriye Sahin Hodoglugil, DrPH
CONTACT
415-353-3400
Nuriye.Sahin-Hodoglugil@ucsf.edu

Principal Investigator

Mary Norton, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Mary Norton, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-01
Study Completion Date2030-01

Study Record Updates

Study Start Date2024-01-01
Study Completion Date2030-01

Terms related to this study

Additional Relevant MeSH Terms

  • Pregnant Individuals Requesting Standard Microarray